Artificial Intelligence (AI) in Oncology Global Markets, 2023-2033: Lucrative Opportunities, Revenue Forecasts, Company Profiles, and Strategic Recommendations - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artificial Intelligence (AI) in Oncology Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.

The overall world revenue for the AI in oncology market, 2023 to 2033 in terms of value will surpass US$2.617 billion in 2023. The report predicts strong revenue growth through to 2033. This work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Market Dynamics

• Driving Factors
  • Early Detection and Diagnosis Fuelling the Growth of AI in Oncology
  • AI Technology Breakthroughs Improved Accuracy and Efficiency
  • Generation of Large and Complex Healthcare Datasets in Driving the Market
• Restraining Factors
  • Security and Privacy of Data Concerns Causes Significant Barriers
  • Lack of Skilled AI Workforce and Cost and Infrastructure Requirement Pose Significant Challenges
• Opportunities
  • Rising Need of Remote Monitoring and Telemedicine
  • Increasing Demand for Personalised Medication is Driving Market Expansion

Accelerated Drug Discovery and Targeted Therapies Driving Market Growth

AI technologies are transforming the drug research and development process in cancer by harnessing massive volumes of data and smart algorithms. These developments seek to speed up the identification of prospective medication candidates, improve their efficacy, and make the development of targeted medicines easier. AI in drug development has the potential to dramatically reduce the time and expense associated with traditional techniques.

Collaborations between pharmaceutical corporations, technology businesses, and academic institutions have increased as a result of the development of AI-driven platforms and tools for drug discovery and development. These collaborations attempt to use AI to accelerate the development of new cancer medicines. For instance, in May 2023, the University of Sydney and the Australian business Pharos Therapeutics agreed to use AI to advance medication discovery for the treatment of cancer and uncommon disorders.

How will this report help you?

In summary, this 280+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for AI in Oncology Market, 2023 to 2033 Market, with forecasts for product types, usage types, disease types and end-users types, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 20 key national markets - See forecasts for the AI in Oncology Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, South Korea, Singapore, Brazil, Mexico, Argentina, Colombia, GCC, South Africa, and among other prominent economies.
• Prospects for established firms and those seeking to enter the market - including company profiles for 16 of the major companies involved in the AI in Oncology Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Key Topics Covered

1 Report Overview

2 Executive Summary

3 Market Overview

4 AI in Oncology Market Analysis by Product Type

5 AI in Oncology Market Analysis by Usage Type

6 AI in Oncology Market Analysis by End-user

7 AI in Oncology Market Analysis by Disease Type

8 AI in Oncology Market Analysis by Region

9 North America AI in Oncology Market Analysis

10 Europe AI in Oncology Market Analysis

11 Asia Pacific AI in Oncology Market Analysis

12 Latin America AI in Oncology Market Analysis

13 MEA AI in Oncology Market Analysis

14 Company Profiles

15 Conclusion and Recommendations

Companies Mentioned

• Azra AI
• Botkin.AI
• CloudMedX
• ConcertAI
• Digital Diagnostics
• Enlitic
• GE Healthcare
• Google Health
• IBM Corporation
• iCAD
• Intel
• NVIDIA
• Owkin
• Siemen's Healthineers
• SkinVision
• Therapixel
• Alphabet
• AstraZeneca
• BenevolentAI
• Carebox Health
• Exscientia
• Kaitek Labs
• Lumea
• Medicsen AI
• Moove Health
• OncoBot
• OncoMedicAI
• Optellum
• Philips
• Sumitomo Dainippon Pharma
• Tempus
• Verily
• and more!

For more information about this report visit https://www.researchandmarkets.com/r/6tm04p

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900